Has Tristan Weaver, MD received payments from drug or device companies?

Yes. Drug and device makers reported $202,328 in general payments to Tristan Weaver, MD across 653 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Tristan Weaver, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Tristan Weaver, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Tristan Weaver, MD

Pain Medicine · Columbus, OHNPI 1952613127

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $168,729 of the $202,328 with a category attached, or 83.4%. Medtronic accounts for 96.7% of it on its own, with 19 other manufacturers making up the rest. Among pain medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$202,328in general payments, 2019–2025

Across 653 payments — averaging $309.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$196K
Boston Scientific$3K
Nevro Corp.$1K
Vertos Medical, Inc.$951
Abbott$383
Vertiflex, Inc.$277
plus $940 from 14 others

$597,292in research payments, 2019–2025

Across 78 payments — averaging $7657.59 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Heron Therapeutics, Inc.$274K
SPR Therapeutics, Inc$194K
Nevro Corp.$54K
Pacira Pharmaceuticals Incorporated$37K
Seikagaku Corporation$20K
Globus Medical$13K
plus $5K from 3 others

What the payments were for

Consulting fees$3,8102%
Speaking & faculty fees$168,72983%
Travel & lodging$14,4607%
Food & beverage$15,3198%
Education$110%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	399	$195,730
Boston Scientific	179	$2,934
Nevro Corp.	24	$1,113
Vertos Medical, Inc.	10	$951
Abbott	6	$383
Vertiflex, Inc.	4	$277
SPR Therapeutics, Inc	3	$265
MML US, Inc.	8	$133
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	2	$114
Relievant Medsystems, Inc.	5	$68
Globus Medical	2	$55
Avanos Medical	1	$54
Nalu Medical, Inc.	2	$49
Spinal Simplicity, LLC	1	$42
Curonix LLC	2	$34
Si-bone, Inc.	1	$31
GRT US Holding, Inc.	1	$30
Stimwave Technologies Incorporated	1	$29
Saluda Medical Americas, Inc.	1	$21
Biotronik NRO, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

INTELLIS ADAPTIVESTIM$88,851
INTELLIS$35,958
VANTA ADAPTIVESTIM$14,265
RESTORE$11,265
SYNCHROMED$8,770
ADAPTIVESTIM$7,060
INCEPTIV$6,554
RESTORESENSORSURESCAN$4,500
SYNCHROMEDII$4,000
Inflate FX$2,000
MYSTIM$1,500
mild Device Kit$616
SPECIFY$500
Senza Spinal Cord Stimulation System$351
Omnia$347
SPRINT PNS System$250
PROCLAIM$250
Superion ISS$243
WaveWriter Alpha Prime 16$236
GENERAL - THERAPIES$116

How this compares

$202,328 in reported general payments places this provider in the 95th percentile of 245 pain medicine providers in Ohio.

See all pain medicine providers in Ohio →

Medicare billing

Part B allowed, 2024

$91,821

Medicare patients

370

Services billed

2,108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Buprenorphine	20	$5,857
Pregabalin	84	$2,176
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	88	$1,980
Gabapentin	173	$1,814
Oxycodone Hcl	58	$1,281
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	83	$658
Morphine Sulfate ErMorphine Sulfate	23	$533
Tizanidine Hcl	13	$486
Acetaminophen-CodeineAcetaminophen With Codeine	28	$366
Tramadol Hcl	54	$236
Nortriptyline Hcl	23	$189
Cephalexin	32	$89
Methylprednisolone	18	$88
Cyclobenzaprine Hcl	12	$61
Ondansetron OdtOndansetron	14	$59

Paid to pharmacies, not to this prescriber.

Other pain medicine in Columbus

Joanna PengColumbus$9K
Cody YergerColumbus$7K
Alexander EscobarToledo$638K
Nagy MekhailCleveland$511K
Henry VuceticWilloughby$509K
Tammy DannDayton$431K
Michael DankoLoveland$381K
Jonathan SilvermanDayton$234K
Robert BolashCleveland$154K
Dmitri SouzaCuyahoga Falls$61K

See the full list for Ohio →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →